STOCK TITAN

Merlin names Robert H. Smith interim CEO and chairman

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Merlin, Inc. (MRLN) appointed Dr. Robert H. Smith interim CEO and chairman effective November 18, 2026, as Matthew George left the CEO, chairman and board roles to become Founder and Advisor. The board is searching for a permanent CEO, considering internal and external candidates. Smith’s initial six-month term may be extended in successive three-month periods by mutual agreement; his monthly salary is $48,000.

Smith will receive restricted stock unit awards for 500,000 shares and 1,500,000 shares. The first vests at the earlier of the six-month anniversary or service conclusion, subject to exceptions for termination for cause or Smith’s early resignation; the second vests monthly, with no fewer than 1,000,000 units vesting if his term ends before 12 months except for cause or early resignation. Unvested portions of both awards vest upon a change of control. George’s advisor role runs to the first anniversary unless he resigns or the company terminates for cause. His terms include $6,250 monthly, a cash payment equal to 1.5 times his current base salary in 18 monthly installments, a target 2026 bonus in a lump sum after the 60th day, and 18 months of subsidized health insurance, conditioned on a release and agreement compliance.

Filing Explained

A change of control within one year can fully vest George’s outstanding awards, with additional cash and health benefits tied to one- and three-year windows.

Merlin signed George’s transition agreement on November 18, 2026; it adds conditional change-of-control payments and equity-vesting outcomes.

If a change of control occurs on or before the third anniversary, the agreement provides extra cash equal to six months of base salary plus one target annual bonus; a change of control by the first anniversary also triggers six months of subsidized health-insurance payments.

George’s outstanding options and time-based restricted stock units continue vesting during his advisory service; upon service termination, all remaining awards vest except if Merlin terminates him for cause or he leaves before the first anniversary other than because of Merlin’s material breach.

In that early-departure case, awards vest only to the amount scheduled through the first anniversary, while a change of control on or before that anniversary vests all then-unvested awards.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Interim CEO monthly salary $48,000 per month Dr. Robert H. Smith’s compensation as Interim Chief Executive Officer
Interim CEO RSU Award 500,000 shares Award to Dr. Robert H. Smith; vests at the earlier of the six-month anniversary or service conclusion, subject to stated exceptions
Additional RSU Award 1,500,000 shares Award to Dr. Robert H. Smith; vests in monthly installments, subject to stated terms
Minimum Additional RSU vesting No fewer than 1,000,000 restricted stock units Applies if Smith’s term concludes before the 12-month anniversary for reasons other than termination for cause or early resignation
Founder and Advisor monthly fee $6,250 per month Matthew George’s independent consultant fee
Transition cash payment 1.5 times current base salary Matthew George’s payment under the Transition Agreement
Transition cash-payment installments 18 monthly installments Matthew George’s transition cash payment
Subsidized health insurance 18 months Matthew George’s transition benefits
restricted stock unit awards technical
"outstanding options and time-based restricted stock unit awards"
Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.
Good Reason technical
"constitutes a resignation for “Good Reason” under the Company’s Executive Severance Plan"
Change in Control technical
"if a Change in Control occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Executive Severance Plan technical
"under the Company’s Executive Severance Plan"
non-compete technical
"includes non-compete, non-solicit of employees and non-interference"
A non-compete is a contract clause that prevents an employee, executive, or seller from working for or starting a rival business for a set time and area after leaving a company. It matters to investors because it protects the value of intellectual property, customer relationships and key personnel—like putting a temporary fence around a company’s customers and know‑how—while also creating legal and operational constraints that can affect talent mobility and deal attractiveness.
standstill agreement technical
"and a standstill agreement for three years following the Effective Date"
A standstill agreement is a contract in which one party agrees to pause certain actions — such as making new claims, enforcing debt remedies, or pursuing a takeover bid — for a set period so both sides can negotiate or restructure. Think of it as a temporary pause button that reduces immediate pressure and uncertainty; investors care because it can protect value, buy time for a deal or restructuring to be completed, and signal the likelihood and timing of future corporate developments.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What compensation and equity awards will MRLN’s interim CEO receive?

Dr. Robert H. Smith will receive $48,000 per month and awards for 500,000 shares and 1,500,000 shares. The first award vests at the earlier of the six-month anniversary or the end of his service, subject to cause and early-resignation exceptions. The second vests monthly; if his term ends before its 12-month anniversary for reasons other than cause or early resignation, no fewer than 1,000,000 units vest.

What change-in-control benefits are included for Matthew George?

If a Change in Control occurs on or before the third anniversary of the effective date, George receives an additional six months of base salary plus one times his target annual bonus. If it occurs on or before the first anniversary, he also receives the value of an additional six months of subsidized health insurance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
FALSE000202870700020287072026-11-182026-11-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 18, 2026

MERLIN, INC.
(Exact name of registrant as specified in its charter)
Delaware001-4239298-1797826
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
100 Causeway St., Floor 23
Boston, MA 02114
(Address of principal executive offices) (Zip Code)
(857) 201-3979
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)
Name of each exchange
on which registered
Common stock, par value $0.0001 per shareMRLN
The Nasdaq Stock Market LLC
(Nasdaq Global Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 18, 2026 (the “Effective Date”), Mr. Matthew George transitioned from serving as the Chief Executive Officer of Merlin, Inc. (“Merlin” or the “Company”) and the Chairman and a member of the Board of Directors of the Company (the “Board”) to the role of Founder and Advisor. In connection with the transition, the Board appointed Dr. Robert H. Smith as Interim Chief Executive Officer and Chairman of the Board. The Board is commencing a search for a permanent CEO and will consider both internal and external candidates.
Biographical Information of Dr. Robert H. Smith
Dr. Smith, age 62, has served as a member of the Board since March 16, 2026. In addition, he has held the roles of Principal at Right Hand Side, a consulting group, and Co-Founder at JATO Foundation since January 2024. Dr. Smith also currently serves as a Senior Advisor to the Office of the Secretary of Defense as part of the Business Operators for National Defense (BOND) program. Prior to that, Dr. Smith was the Chief Executive Officer of Blue Origin, a space startup, from September 2017 until January 2024. Dr. Smith also held various leadership roles in the aerospace industry prior to joining Blue Origin, including at Honeywell Aerospace — where he served in various roles from July 2004 to August 2017 including Chief Technology Officer & President of Mechanical Systems & Components, as well as other roles at United Space Alliance and The Aerospace Corporation. Dr. Smith also currently serves as a director of Parsons Corporation (NYSE: PSN), a role he has held since April 2024 and as an independent director Seurat Technologies, an additive manufacturing company. Dr. Smith holds a bachelor’s degree from Texas A&M in Aerospace Engineering, a master’s degree from Brown in Applied Math and Engineering, a master’s degree from the MIT Sloan School of Management and a Ph.D. in Aerospace Engineering from The University of Texas at Austin.
There are no arrangements or understandings between Dr. Smith and any other person pursuant to which Dr. Smith was selected as Interim Chief Executive Officer, other than with directors or officers of the Company acting solely in those capacities. There are no family relationships between Dr. Smith and any director or executive officer of the Company or person nominated or chosen for either role. Dr. Smith has no direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.
Transition Agreement with Mr. Matthew George
On November 18, 2026, in connection with Mr. George’s transition from Chief Executive Officer and Chairman and member of the Board to the role of Founder and Advisor, the Company entered into a Transition Agreement with Mr. George (the “Transition Agreement”) that sets forth the terms of Mr. George’s Founder and Advisor role and the amounts payable to Mr. George in connection with the conclusion of his employment as Chief Executive Officer. Mr. George will serve as Founder and Advisor until the first anniversary of the Effective Date, unless earlier terminated by Mr. George for any reason or by the Company for cause. As an independent consultant, Mr. George will receive a monthly fee of $6,250 (pro-rated for partial months) and, at the reasonable request of the Company, will assist in the orderly transition of his duties and responsibilities to such other persons as the Company designates and will provide advice to the Board when and as reasonably requested by the Board and agreed to by Mr. George.
Mr. George’s transition from Chief Executive Officer and Chairman and member of the Board constitutes a resignation for “Good Reason” under the Company’s Executive Severance Plan (the “Severance Plan”). The Transition Agreement provides:
•Mr. George will receive (i) a cash payment equal to one and one-half times his current base salary, paid in eighteen monthly installments, (ii) a 2026 annual bonus, based on target performance and paid in a lump sum following the sixtieth (60th) day after the Effective Date, (iii) eighteen months of subsidized health insurance payments, and (iv) if a Change in Control (as defined in the Severance Plan) occurs (A) on or prior to the third anniversary of the Effective Date, an additional cash payment equal to an additional six months of base salary plus one times his target annual bonus, and (B) on or prior to the first anniversary of the Effective Date, the value of an additional six months of subsidized health insurance; and
•Mr. George’s outstanding options and time-based restricted stock unit awards will continue to vest under the terms of the applicable award agreements and equity incentive plans during the time he serves as Founder and Advisor and, (i) upon termination of Mr. George’s service as Founder and Advisor for any reason other than a termination by the Company for cause or a termination by Mr. George prior to the first anniversary of the Effective Date other than as a result of the Company’s material breach of the Transition Agreement, each then unvested option and restricted stock unit award will become vested and, with respect to the options, exercisable, (ii) if Mr. George



terminates his service prior to the first anniversary of the Effective Date other than as a result of the Company’s material breach of the Transition Agreement, the portion of each award that would have vested through such first anniversary will become vested and, with respect to options, exercisable, or (iii) if a Change of Control occurs on or prior to the first anniversary of the Effective Date, Mr. George’s then-outstanding and unvested equity awards will vest in full.
The Transition Agreement includes non-compete, non-solicit of employees and non-interference with business restrictions, in each case, for the duration of Mr. George’s service as Founder and Advisor, and a standstill agreement for three years following the Effective Date. Mr. George’s service as Founder and Advisor and the above payments and benefits provided to Mr. George pursuant to the Transition Agreement are conditioned on his execution and nonrevocation of a release of claims in favor of the Company and such payments and benefits are also conditioned on his compliance with the terms of the Transition Agreement.
The foregoing summary is qualified in its entirety by reference to the Transition Agreement, which is attached as Exhibit 10.1 to this current report on Form 8-K and which is incorporated by reference into this Item 5.02 and will be filed as an exhibit to the Company’s Form 10-K for the fiscal year ending December 31, 2026.
Offer Letter for Dr. Robert H. Smith
On November 18, 2026, the Company and Dr. Smith entered into a letter agreement (the “Offer Letter”) establishing Dr. Smith’s compensation as Interim Chief Executive Officer of the Company. Dr. Smith’s service as Interim Chief Executive Officer will continue for six months, subject to extension for successive three-month periods on mutual agreement, and will conclude on the first to occur of (a) the date a permanent successor Chief Executive Officer is appointed by the Board, (b) the conclusion of the initial term or a successive term without mutual agreement to continue, or (c) resignation or termination for any reason.
Under the Offer Letter, Dr. Smith’s compensation will consist of a monthly salary of $48,000, prorated for partial months. As additional compensation, Dr. Smith will receive two restricted stock unit awards: (i) an award for 500,000 shares (the “Interim CEO RSU Award”), which will vest on the earlier of the six-month anniversary of the Effective Date or the date Dr. Smith’s service as Interim Chief Executive Officer concludes, so long as such conclusion is not the result of a termination by the Company for cause or an early resignation by Dr. Smith, and (ii) an award for 1,500,000 shares (the “Additional RSU Award”) which will vest in twelve monthly installments, so long as Dr. Smith continues to serve as Interim Chief Executive Officer; provided that, in the event the term concludes prior to the 12-month anniversary of the Effective Date for any reason other than a termination by the Company for cause or early resignation by Dr. Smith, no fewer than 1,000,000 of the restricted stock units subject to the Additional RSU Award will vest. Any unvested portions of the Interim CEO RSU Award and the Additional RSU Award will vest upon a change of control of the Company (as defined in Merlin, Inc.’s 2026 Incentive Award Plan (the “LTIP”)). The Interim CEO RSU Award and the Additional RSU Award will be granted under and subject to the terms and conditions of the LTIP.
During his term as Interim Chief Executive Officer, Dr. Smith will be eligible for benefits consistent with those of senior management and reimbursement of reasonable business expenses under Company policies, including temporary housing near the Company’s headquarters. Dr. Smith will not be eligible to participate in the Severance Plan or any similar Company plan or policy. After his service as Interim Chief Executive Officer ends, he will be compensated under the applicable non-employee director compensation program for so long as he continues to serve as a director.
The foregoing summary is qualified in its entirety by reference to the Offer Letter, which is attached as Exhibit 10.2 to this current report on Form 8-K and which is incorporated by reference into this Item 5.02, will be filed as an exhibit to the Company’s Form 10-K for the fiscal year ending December 31, 2026.
Item 8.01. Other Events.
On November 19, 2026, the Company issued a press release announcing an executive leadership change, a copy of which is filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.



Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.Description
10.1
Transition Agreement, dated as of November 18, 2026, between Merlin, Inc. and Matthew George.
10.2
Offer Letter, dated as of November 18, 2026, between Merlin, Inc. and Robert H. Smith.
99.1
Press Release of Merlin, Inc., dated November 19, 2026.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 19, 2026MERLIN, INC.
By:/s/ Leslie Ravestein
Name: Leslie Ravestein
Title: Chief Legal Officer and Secretary


Exhibit 99.1
Merlin Names Veteran Aerospace and Defense Executive Bob Smith Chairman and Interim Chief Executive Officer

Smith to focus on delivering autonomy to defense customers for the next century of flight

BOSTON, November 19, 2026 — Merlin, Inc. (Nasdaq: MRLN), an aerospace and defense technology company building the operating system of record for autonomous flight, today announced that its Board of Directors has appointed Bob Smith, a member of the Board, as Chairman and Interim Chief Executive Officer, effective November 18, 2026. Smith succeeds founder Matt George, who has resigned as Chief Executive Officer, Chairman, and a member of the Board of Directors and has transitioned to the role of Founder and Advisor.

Smith brings more than three decades of aerospace and defense leadership. As Chief Executive Officer of Blue Origin from 2017 to 2024, he transitioned the company from a research organization into an operating business, growing annual sales from nearly zero to more than $750 million and building an order book of approximately $10 billion. Previously, he spent more than a decade at Honeywell Aerospace, including as President of Mechanical Systems and Components, a business with more than $4 billion in annual revenue, and as Chief Technology Officer, responsible for more than 12,000 engineers and technologists. Prior to Honeywell, he worked on upgrading the NASA space shuttle at United Space Alliance. He also currently serves as a Senior Advisor to the Office of the Secretary of Defense as part of the Business Operators for National Defense (BOND) program and as a director of Parsons Corporation.

“Matt and this team built something incredibly novel and needed, and I’m thankful for Matt’s vision and leadership. Merlin’s autonomy software is flying today, and as we enter our next phase, our priorities are clear: deliver for our customers, including USSOCOM and AFRICOM programs; grow our pipeline; keep building Merlin Pilot; and invest with discipline to protect our strong balance sheet. It’s a great team, and I’m eager to get to work,” said Bob Smith.

“Merlin has enormous potential, and Bob is exactly the proven leader we need to unlock it,” said Michael Blitzer, Lead Independent Director of Merlin’s Board of Directors. “Having served as CEO of one of the world’s largest aerospace companies, he brings a powerful combination of commercial acumen to accelerate revenue growth and operational discipline to fundamentally improve our cost structure. Bob has a proven track record of building and leading businesses at scale, and I’m confident he is the right person to transform Merlin’s trajectory, drive sustainable profitability, and create significant long-term shareholder value. The Board is commencing a search for a permanent CEO and will consider both internal and external candidates.”

“Building Merlin with this team has been the privilege of my career. Together we took autonomy from an idea to aircraft flying for real customers. I’m proud of what we’ve built, and I’m confident Merlin is in good hands,” said Matt George.

About Merlin
Merlin is an aerospace and defense technology company building the operating system of record for autonomous flight. Through a first-principles approach, the company is redefining what’s possible across aviation, aerospace, and defense with the goal of delivering full-stack autonomy for any aircraft, military or civilian, from takeoff to touchdown. The Merlin Pilot system powers a growing range of aircraft and mission profiles, proven through hundreds of autonomous flights from test facilities across the globe. With $100M+ total in IDIQ contract ceiling value under its C-130J autonomy program with USSOCOM, Merlin is advancing American leadership in autonomous aviation by helping to solve national security challenges through safe, reliable autonomy. To learn more, visit www.merlinlabs.com or follow us on X @merlinaero.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding Merlin’s future performance and the Chief Executive Officer transition. These statements reflect management’s current expectations based on information available at the date of this release and involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Important factors that could cause actual results to differ materially include, but are not limited to: the transition of Merlin’s leadership, including the potential for disruption to Merlin’s business, operations, and customer and employee relationships; and the other risks and uncertainties described under “Risk Factors” in our final prospectus, dated May 13, 2026, filed with the Securities and Exchange Commission (the “SEC”) on May 13, 2026, and in other documents we subsequently file with the SEC. Merlin does not undertake any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.





Contacts
Investor Relations: investor.relations@merlinlabs.com
Media: media@merlinlabs.com



Filing Exhibits & Attachments

6 documents

Keep reading